3MO Axillary management strategies in breast cancer patients with ypN0 after neoadjuvant therapy
Conferences
Shang, Q; Zhuang, Y; Luo, S; Wang, X
Published in: Annals of Oncology
December 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
December 2025
Volume
36
Start / End Page
S1766 / S1766
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shang, Q., Zhuang, Y., Luo, S., & Wang, X. (2025). 3MO Axillary management strategies in breast cancer patients with ypN0 after neoadjuvant therapy. In Annals of Oncology (Vol. 36, pp. S1766–S1766). Elsevier BV. https://doi.org/10.1016/j.annonc.2025.10.837
Shang, Q., Y. Zhuang, S. Luo, and X. Wang. “3MO Axillary management strategies in breast cancer patients with ypN0 after neoadjuvant therapy.” In Annals of Oncology, 36:S1766–S1766. Elsevier BV, 2025. https://doi.org/10.1016/j.annonc.2025.10.837.
Shang Q, Zhuang Y, Luo S, Wang X. 3MO Axillary management strategies in breast cancer patients with ypN0 after neoadjuvant therapy. In: Annals of Oncology. Elsevier BV; 2025. p. S1766–S1766.
Shang, Q., et al. “3MO Axillary management strategies in breast cancer patients with ypN0 after neoadjuvant therapy.” Annals of Oncology, vol. 36, Elsevier BV, 2025, pp. S1766–S1766. Crossref, doi:10.1016/j.annonc.2025.10.837.
Shang Q, Zhuang Y, Luo S, Wang X. 3MO Axillary management strategies in breast cancer patients with ypN0 after neoadjuvant therapy. Annals of Oncology. Elsevier BV; 2025. p. S1766–S1766.
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
December 2025
Volume
36
Start / End Page
S1766 / S1766
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences